NCT05172245 2026-03-18
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1 Recruiting
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
NRG Oncology
AstraZeneca
Icahn School of Medicine at Mount Sinai
Tata Memorial Centre
Washington University School of Medicine
H. Lee Moffitt Cancer Center and Research Institute